Tarsus Pharmaceuticals is based in Princeton, NJ. It has raised $260M in total funding. Latest round: IPO. Backed by Pharmakon.
Tarsus Pharmaceuticals funding overview
Tarsus Pharmaceuticals is based in Princeton, NJ. Tarsus Pharmaceuticals has raised $260M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in October 2020. The round record for Tarsus Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include Pharmakon.
Tarsus Pharmaceuticals at a glance
Total raised
$260M
Latest round
IPO
Latest round date
October 2020
Headquarters
Princeton, NJ
Notable investors
Pharmakon
Frequently asked about Tarsus Pharmaceuticals funding
How much has Tarsus Pharmaceuticals raised?
Tarsus Pharmaceuticals has raised $260M in total disclosed funding across the rounds on record.
Who has invested in Tarsus Pharmaceuticals?
Pharmakon are named among the investors backing Tarsus Pharmaceuticals.
What was the latest Tarsus Pharmaceuticals funding round?
The most recent disclosed round is an IPO, announced in October 2020.
Where is Tarsus Pharmaceuticals based?
Tarsus Pharmaceuticals is based in Princeton, NJ.
When did Tarsus Pharmaceuticals last raise?
The last disclosed Tarsus Pharmaceuticals round closed in October 2020 at IPO.
We update the Tarsus Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Princeton and their backers are listed below.
